CLEVELAND DIAGNOSTICS
Cleveland Diagnostics is a commercial-stage diagnostics company developing efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. Its solvent interaction analysis technology investigates protein biomarkers at the structural level, providing better and more direct insights regarding the protein origin on the cellular level, thus improving test specificity to the underlying disease process. Its portfolio of non-invasive cancer diagnostics will be expanding from prostate cancer to breast cancer and lung cancer, and certain neurological diseases.
CLEVELAND DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2013-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.clevelanddx.com
Total Employee:
11+
Status:
Active
Contact:
+1 216 432 2700
Email Addresses:
[email protected]
Total Funding:
35.98 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
NanoCellect Biomedical
NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Current Employees Featured
Founder
Investors List
LYFE Capital
LYFE Capital investment in Series D - Cleveland Diagnostics
Cleveland Clinic
Cleveland Clinic investment in Series D - Cleveland Diagnostics
Genomic Health
Genomic Health investment in Convertible Note - Cleveland Diagnostics
Official Site Inspections
http://www.clevelanddx.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Cleveland Diagnostics"
Cancer Testing - Cleveland Diagnostics
Cleveland Diagnostics was co-founded by the Cleveland Clinic, one of the world’s most highly regarded hospital systems.See details»
Leadership - Cleveland Diagnostics
Arnon Chait, PhD, MBA President & CEO Cleveland Diagnostics. Joseph Rich, JD Senior Director, Governance, Grants and Policies Cleveland Clinic VenturesSee details»
Cleveland Diagnostics - Crunchbase Company Profile …
Contact Email [email protected] Phone Number +1 216 432 2700 Cleveland Diagnostics is a commercial-stage diagnostics company developing efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to …See details»
Cleveland Diagnostics Completes $75M Financing to Advance its …
Jan 17, 2024 Media Contact Liz Robinson Account Supervisor at CG Life [email protected] 847-702-8099 Investor Contact David Holmes Gilmartin Group …See details»
ClevelandDx Company Profile 2024: Valuation, Funding …
ClevelandDx General Information Description. Developer of a medical technology designed to detect cancer early when it can be treated and cured. The company's technology evaluates the changes to the structure of the protein biomarker …See details»
Cleveland Diagnostics Completes $75M Financing to Advance its …
CLEVELAND, January 17, 2024--Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing PlatformSee details»
Cleveland Diagnostics Receives College of American …
May 5, 2021 Visit us at ClevelandDx.com and IsoPSA.com. About the College of American Pathologists. As the world’s largest organization of board-certified pathologists and leading provider of laboratory ...See details»
Cleveland Diagnostics Completes $75M Financing to Advance its …
Jan 16, 2024 Learn more at ClevelandDx.com and IsoPSA.com. About Novo Holdings. Novo Holdings is a holding and investment company that is responsible for managing the assets and …See details»
Cleveland Diagnostics, Inc. Raises Over $19 Million in …
Feb 9, 2021 Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, anSee details»
Cleveland Diagnostics Opens New Facility Amid Growing Demand …
CLEVELAND – (June 28, 2023) -- Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has …See details»
Cleveland Diagnostics re-ups prostate-specific antigen test push
Aug 27, 2024 This marks the second year for the “A PSA on PSA” campaign, which ClevelandDx started in 2023 to educate patients and their families and caregivers about the …See details»
CME — Cleveland Diagnostics
The opinions expressed are solely those of the faculty and do not reflect those of ClevelandDx. Please refer to clevelanddx.com for complete information. CME Banner. CME Prostate Cancer …See details»
The IsoPSA Test Is Available, and It Could Change the Diagnostic ...
Jul 7, 2020 Questions about the test can be directed to Dr. Klein ([email protected]) or Bob Rochelle, MBA, Chief Commercial Officer, Cleveland Diagnostics …See details»
Cleveland Diagnostics Opens New Facility Amid Growing Demand …
Jun 28, 2023 Liz Robinson [email protected] 312-997-2436 Release Summary. Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test. …See details»
Cleveland Diagnostics Receives Support from JobsOhio
Nov 8, 2021 Its portfolio of non-invasive cancer diagnostics will be expanding from prostate cancer to breast cancer and lung cancer, and certain neurological diseases. Visit us at …See details»
Cleveland Diagnostics Opens New Facility Amid Growing Demand …
Jun 29, 2023 Please visit us at ClevelandDx.com. Contacts. Liz Robinson [email protected] 312-997-2436 . 250 First Avenue, Suite 300 Needham, MA 02494 …See details»
Cleveland Diagnostics Closes $75M Private Financing | 360Dx
Jan 17, 2024 NEW YORK — Cleveland Diagnostics said Wednesday that it has closed $75 million in a private financing. The company said it plans to use the funds to support …See details»
NEWS & MEDIA — Cleveland Diagnostics
Eric Klein, MD from the Glickman Urological and Kidney Institute at the Cleveland Clinic speaks about the AUA 2021 Abstract - MP60-03 IsoPSA: Clinical performance of a single parameter, …See details»
Cleveland Diagnostics Presents New Data Supporting the Clinical ...
Sep 14, 2021 Cleveland Diagnostics, Inc. Bob Rochelle Phone: (216) 432-2700, Ext. 2119 [email protected] Release Summary IsoPSA demonstrates significant clinical …See details»